

Lixte Biotechnology Holdings, a clinical-stage pharmaceutical company, focuses on discovering drugs for more effective cancer treatments. Among its major competitors, Lixte Biotechnology Holdings is ranked in 6th place for NPS while Biogen is 1st, and Athersys is 2nd.